Alicaforsen
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Alicaforsen, covering 2020-02-25 to 2022-12-05. Get the full timeline:
Most recent: Clinical Trial Update: ISIS 2302-CS27, A 6-Week, Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis. [Phase 2]